Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women

Fertility and Sterility

Volumn 86, Issue 4, 2006, Pages 899-904

  Cicinelli, Ettore ^a   Ranieri, Giuseppe ^a   Maffei, Silvia ^b   Colafiglio, Giuseppe ^a   Ria, Roberto ^a   Bellavia, Marina ^a   Schonauer, Matteo M ^a  

^a UNIVERSITY OF BARI   (Italy)

^b CNR   (Italy)

Author keywords

cell adhesion molecules; E selectin; ICAM 1; postmenopausal women; Tibolone; VCAM 1

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; TIBOLONE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD LEVEL; CELL ADHESION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HEART PROTECTION; HUMAN; LONG TERM EXPOSURE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

CROSS-OVER STUDIES; E-SELECTIN; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NORPREGNENES; PLACEBO EFFECT; POSTMENOPAUSE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33749238165     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.03.041     Document Type: Article

References (32)

1. Hennekens C.H. Risk factors for coronary heart disease in women. Cardiol Clin 16 (1998) 1-8
2. Lerner D.J., and Kannel W.B. Patterns of coronary heart disease in women: perspective from the Framingham study. Am Heart J 113 (1986) 383-390
3. Herrington D.M., Braden G.A., Williams J.K., and Morgan T.M. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and with-out estrogen replacement therapy. Am J Cardiol 73 (1994) 951-952
4. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. CRP and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
5. Williams J.K., Adams M.R., and Klopfenstein H.S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81 (1990) 1680-1687
6. Sbarouni E., Kroupis C., Kyriakides S., Koniavitou K., and Kremastinos D.T. Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease. Eur Heart J 21 (2000) 975-980
7. Marchien van Baal W., Kenemans P., Emeis J.J., Schalkwijk C.G., Mijatovic V., van der Mooren M.J., et al. Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women. Fertil Steril 71 (1999) 663-670
8. Walsh B.W., Paul S., Wild R.A., Dean R.A., Tracy R.P., Cox D.A., et al. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 85 (2000) 214-218
9. Krasinski K., Spyridoupoulos I., Asahara T., Zee van der R., Isner J.M., and Losordo D.W. Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 95 (1997) 1768-1772
10. Wilcox J.G., Hatch I.E., Gentzschein E., Stanczyk F.Z., and Lobo R.A. Endothelin levels decrease after oral and non-oral estrogen in postmenopausal women with increased cardiovascular risk factor. Fertil Steril 67 (1997) 273-277
11. Maudelonde T., Brouillet J.P., and Pujol P. Anti-estrogens, selective estrogen receptor modulators (SERM), tibolone: modes of action. Contracept Fertil Sex 27 (1999) 620-624
12. Moore R.A. Livial-a review of clinical studies. Br J Obstet Gynaecol 106 Suppl 19 (1999) 1-21
13. Castelo-Branco C., Casals E., Figueras F., Sanjuan A., Vicente J.J., Balasch J., et al. Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B. Menopause 6 (1999) 92-97
14. Zandberg P., Peters J.L.M., Demacker P.N., de Reeder E.G., Smit M.J., and Meuleman D.G. Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbits. Menopause 8 (2001) 96-105
15. Haenggi W., Bersinger N.A., Mueller M.D., and Birkhaeuser M.H. Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone. Gynecol Endocrinol 13 (1999) 202-205
16. Zoma W., Baker R.S., Lang U., and Clark K.E. Hemodynamic response to tibolone in reproductive and nonreproductive tissues in the sheep. Am J Obstet Gynecol 184 (2001) 544-551
17. Cicinelli E., Ignarro L.J., Galantino P., Pinto V., Barba B., and Schonauer S. Effects of tibolone on plasma levels of nitric oxide in postmenopausal women. Fertil Steril 78 (2002) 464-468
18. Simoncini T., and Genazzani A.R. Tibolone inhibits leukocyte adhesion molecule expression in human endothelial cells. Mol Cell Endocrinol 162 (2000) 87-94
19. Register T.C., Wagner J.D., Zhang L., Hall J., and Clarkson T.B. Effects of tibolone and conventional hormone replacement therapies on arterial and hepatic cholesterol accumulation and on circulating endothelin-1, vascular cell adhesion molecule-1, and E-selectin in surgically menopausal monkeys. Menopause 9 (2002) 411-421
20. Egarter C., Sator M., and Huber J. Effects of tibolone on cell adhesion molecules in postmenopausal women. Menopause 10 (2003) 218-221
21. Sator K., Sator M.O., Sator P.G., Egarter C., and Huber J.C. Effects of tibolone on selectins in postmenopausal women. Maturitas 53 (2006) 166-170
22. Farzati A., Esposito K., Colacurci N., Fornaro F., Chiantera V., and Farzati B. Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women. Fertil Steril 77 (2002) 476-480
23. Van Baal W.M., Emeis J.J., Kenemans P., Kessel H., Peters-Muller E.R., Schalkwijk C.G., et al. Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules. Eur J Clin Invest 29 (1999) 913-921
24. Oger E., Alhenc-Gelas M., Plu-Bureau G., Mennen L., Cambillau M., Guize L., et al. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users. Thromb Res 101 (2001) 35-43
25. Zanger D., Yang B.K., Ardans J., Waclawiw M.A., Csako G., Wahl L.M., et al. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management. J Am Coll Cardiol 36 (2000) 1797-1802
26. Barnes J.F., Farish E., Rankin M., and Hart D.M. Effects of two continuous hormone therapy regimens on C-reactive protein and homocysteine. Menopause 12 (2005) 92-98
27. Christodoulakos G., Lambrinoudaki I., Panoulis C., Papadias C., Sarandakou A., Liakakos T., et al. Effect of hormone therapy, tibolone and raloxifene on circulating vascular endothelial growth factor in Greek postmenopausal women. Eur J Endocrinol 151 (2004) 187-192
28. Lloyd G., McGing E., Cooper A., Patel N., Lumb P.J., Wierzbicki A.S., et al. A randomised placebo controlled trial of the effects of tibolone on blood pressure and lipids in hypertensive women. J Hum Hypertens 14 (2000) 99-104
29. Laan E., van Lunsen R.H., and Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 4 (2001) 28-41
30. Silvestri A., Gambacciani M., Vitale C., Monteleone P., Ciaponi M., Fini M., et al. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk. Maturitas 50 (2005) 305-311
31. Doren M., Rubig A., Coelingh Bennink H.J., and Holzgreve W. Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Am J Obstet Gynecol 183 (2000) 575-582
32. Taioli E., Garte S.J., Trachman J., Garbers S., Sepkovic D.W., Osborne M.P., et al. Ethnic differences in estrogen metabolism in healthy women. J Natl Cancer Inst 88 (1996) 617